Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,365,673
-
Total 13F shares
-
42,639,196
-
Share change
-
+3,063,791
-
Total reported value
-
$225,970,611
-
Put/Call ratio
-
9.6%
-
Price per share
-
$5.30
-
Number of holders
-
88
-
Value change
-
+$18,484,174
-
Number of buys
-
58
-
Number of sells
-
21
Institutional Holders of POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) as of Q4 2022
As of 31 Dec 2022,
POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,639,196 shares.
The largest 10 holders included
FMR LLC, Pentwater Capital Management LP, EcoR1 Capital, LLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, and Cormorant Asset Management, LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.